ALDH2 and ovarian cancer: Another piece of evidence to support ALDH2’s role in ovarian cancer is that the risk of ovarian cancer goes up with age, and ALDH2*2 homozygous genotype was significantly reduced in females in the 60–70s age group versus 40–50s group in a study with more than 2,200 Japanese [104].